1315 Capital II, a 10% Holder, acquired 303,350 Common Shares on a control or direction basis for registered holder 1315 Capital II, LP at a price of US$10.000 through a prospectus or prospectus exempt offering on June 14th, 2021. This represents a $3,683,276 investment into the company's shares and an account share holdings change of 17.1%.
Greenbrook TMS is in the Healthcare Facilities & Services Sub Industry Group under the Healthcare Sector.
Greenbrook TMS Inc is a Canada-based company that offers transcranial magnetic stimulation (TMS) therapy. The TMS therapy is a non-invasive therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. The TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. It operates through approximately 124 Company-operated treatment centers.
No Comments